NCT00776750View on ClinicalTrials.gov

Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

407

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
HemodialysisRenal Transplantation
Interventions
BIOLOGICAL

trivalent split influenza vaccine

standard dose of 0.5 ml commercially available trivalent split influenza vaccine (Vaxigrip®, Aventis Pasteur MSD) by intramuscular injection

Trial Locations (1)

3000

University Hospital Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT00776750 - Influenza Vaccination in Hemodialysis Patients and Renal Transplant Recipients | Biotech Hunter | Biotech Hunter